SEC Form 4 · accession 0001209191-15-056796
ROCKET PHARMACEUTICALS, INC. · RCKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William K. McVicar
Officer — See Remarks
Period of report
Jun 24, 2015
Accepted (ET)
Jun 26, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001281895
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $5.03 | Jun 24, 2015 | A | 75,000 | A | — | Jun 23, 2025 | Common Stock | 75,000 | 276,094 | D |
Explanation of responses
- F1The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. 25% of the options granted shall vest on the one year anniversary of February 17, 2015 and 1/36th of the remaining option grant shall vest on each monthly anniversary thereafter, subject to continued service through such dates.
Remarks
Executive Vice President, Chief Scientific Officer Exhibit List Exhibit 24 - Power of Attorney